271 related articles for article (PubMed ID: 30935582)
1. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.
Chadha AS; Gunther JR; Hsieh CE; Aliru M; Mahadevan LS; Venkatesulu BP; Crane CH; Das P; Herman JM; Koay EJ; Taniguchi C; Holliday EB; Minsky BD; Suh Y; Park P; Sawakuchi G; Beddar S; Odisio BC; Gupta S; Loyer E; Kaur H; Raghav K; Javle MM; Kaseb AO; Krishnan S
Radiother Oncol; 2019 Apr; 133():54-61. PubMed ID: 30935582
[TBL] [Abstract][Full Text] [Related]
2. Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis.
Kim DY; Park JW; Kim TH; Kim BH; Moon SH; Kim SS; Woo SM; Koh YH; Lee WJ; Kim CM
Radiother Oncol; 2017 Jan; 122(1):122-129. PubMed ID: 28034460
[TBL] [Abstract][Full Text] [Related]
3. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Hong TS; Wo JY; Yeap BY; Ben-Josef E; McDonnell EI; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Goyal L; Murphy JE; Javle MM; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Yoon SS; Tanabe KK; Ferrone CR; Ryan DP; DeLaney TF; Crane CH; Zhu AX
J Clin Oncol; 2016 Feb; 34(5):460-8. PubMed ID: 26668346
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group.
Parzen JS; Hartsell W; Chang J; Apisarnthanarax S; Molitoris J; Durci M; Tsai H; Urbanic J; Ashman J; Vargas C; Stevens C; Kabolizadeh P
Radiat Oncol; 2020 Nov; 15(1):255. PubMed ID: 33148296
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma.
Fukuda K; Okumura T; Abei M; Fukumitsu N; Ishige K; Mizumoto M; Hasegawa N; Numajiri H; Ohnishi K; Ishikawa H; Tsuboi K; Sakurai H; Hyodo I
Cancer Sci; 2017 Mar; 108(3):497-503. PubMed ID: 28012214
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Lee SU; Park JW; Kim TH; Kim YJ; Woo SM; Koh YH; Lee WJ; Park SJ; Kim DY; Kim CM
Strahlenther Onkol; 2014 Sep; 190(9):806-14. PubMed ID: 24589917
[TBL] [Abstract][Full Text] [Related]
7. Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.
Sanford NN; Pursley J; Noe B; Yeap BY; Goyal L; Clark JW; Allen JN; Blaszkowsky LS; Ryan DP; Ferrone CR; Tanabe KK; Qadan M; Crane CH; Koay EJ; Eyler C; DeLaney TF; Zhu AX; Wo JY; Grassberger C; Hong TS
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):64-72. PubMed ID: 30684667
[TBL] [Abstract][Full Text] [Related]
8. Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapy.
Mizumoto M; Oshiro Y; Okumura T; Fukuda K; Fukumitsu N; Abei M; Ishikawa H; Ohnishi K; Numajiri H; Tsuboi K; Sakurai H
Radiother Oncol; 2014 Oct; 113(1):54-9. PubMed ID: 25248924
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
Hsieh CE; Venkatesulu BP; Lee CH; Hung SP; Wong PF; Aithala SP; Kim BK; Rao A; Tung-Chieh Chang J; Tsang NM; Wang CC; Lee CC; Lin CC; Tseng JH; Chou WC; Wang YC; Krishnan S; Hong JH
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):73-86. PubMed ID: 30797890
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.
Iizumi T; Okumura T; Sekino Y; Takahashi H; Tsai YL; Takizawa D; Ishida T; Hiroshima Y; Nakamura M; Shimizu S; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
J Radiat Res; 2021 Jul; 62(4):682-687. PubMed ID: 34036362
[TBL] [Abstract][Full Text] [Related]
11. Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis.
Sugahara S; Nakayama H; Fukuda K; Mizumoto M; Tokita M; Abei M; Shoda J; Matsuzaki Y; Thono E; Tsuboi K; Tokuuye K
Strahlenther Onkol; 2009 Dec; 185(12):782-8. PubMed ID: 20013087
[TBL] [Abstract][Full Text] [Related]
12. Proton beam therapy for hepatocellular carcinoma.
Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
[TBL] [Abstract][Full Text] [Related]
13. High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study.
Kong XQ; Dong YP; Wu JX; He JY; Le YY; Du KX; Peng QQ; Li JL
Radiat Oncol; 2017 May; 12(1):92. PubMed ID: 28569169
[TBL] [Abstract][Full Text] [Related]
14. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
Kim TH; Koh YH; Kim BH; Kim MJ; Lee JH; Park B; Park JW
J Hepatol; 2021 Mar; 74(3):603-612. PubMed ID: 33031846
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy in hepatocellular carcinoma: patient selection and predictors of outcome and toxicity.
Loi M; Comito T; Franzese C; Dominici L; Lo Faro L; Clerici E; Franceschini D; Mancosu P; Reggiori G; Gallo P; Badalamenti M; Scorsetti M
J Cancer Res Clin Oncol; 2021 Mar; 147(3):927-936. PubMed ID: 32945972
[TBL] [Abstract][Full Text] [Related]
16. Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.
Sekino Y; Okumura T; Fukumitsu N; Iizumi T; Numajiri H; Mizumoto M; Nakai K; Nonaka T; Ishikawa H; Sakurai H
J Cancer Res Clin Oncol; 2020 Mar; 146(3):711-720. PubMed ID: 31776663
[TBL] [Abstract][Full Text] [Related]
17. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis.
Hata M; Tokuuye K; Sugahara S; Fukumitsu N; Hashimoto T; Ohnishi K; Nemoto K; Ohara K; Matsuzaki Y; Akine Y
Strahlenther Onkol; 2006 Dec; 182(12):713-20. PubMed ID: 17149578
[TBL] [Abstract][Full Text] [Related]
18. Dose-Response Relationship in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Pooled Analysis of an Asian Liver Radiation Therapy Group Study.
Kim N; Cheng J; Huang WY; Kimura T; Zeng ZC; Lee VHF; Kay CS; Seong J
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):464-473. PubMed ID: 33229165
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography-guided iodine-125 brachytherapy for unresectable hepatocellular carcinoma.
Song Z; Ye J; Wang Y; Li Y; Wang W
J Cancer Res Ther; 2019; 15(7):1553-1560. PubMed ID: 31939437
[TBL] [Abstract][Full Text] [Related]
20. A validated proton beam therapy patch-field protocol for effective treatment of large hepatocellular carcinoma.
Nakamura M; Fukumitsu N; Kamizawa S; Numajiri H; Nemoto Murofushi K; Ohnishi K; Aihara T; Ishikawa H; Okumura T; Tsuboi K; Sakurai H
J Radiat Res; 2018 Sep; 59(5):632-638. PubMed ID: 30085200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]